Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ascorbic Acid in Colon Cancer: From the Basic to the Clinical Applications.

International journal of molecular sciences - 13 Sept 2018

El Halabi Ibrahim, Bejjany Rachelle, Nasr Rihab, Mukherji Deborah, Temraz Sally, Nassar Farah J, El Darsa Haidar, Shamseddine Ali

Abstract excerpt

Given the safety and potential benefits of intravenous ascorbic acid (AA) administration in cancer patients, there is merit in further exploring this therapeutic concept. In this review, we discuss the potential benefits of intravenous AA administration on colorectal cancer and we specifically focus on its effect on glycolysis in mutant and wild type RAS. We perform a PubMed and Ovid MEDLINE search using ascorbic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ascorbic Acid
Share to Colonic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Signal Transduction

Source

Open in PubMed Open full text

Identifiers

PMID: 30217071
DOI: 10.3390/ijms19092752
PMCID: PMC6164730

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ascorbic Acid in Colon Cancer: From the Basic to the Clinical Applications.PMID 30217071Read ↗

Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer.Semantic proximity Read ↗

Vitamin C selectively kills <i>KRAS</i> and <i>BRAF</i> mutant colorectal cancer cells by targeting GAPDHSemantic proximity Read ↗

Vitamin C administration by intravenous infusion increases tumour ascorbate content in patients with colon cancer: a clinical intervention studySemantic proximity Read ↗

Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic KRAS mutant colon cancer.Semantic proximity Read ↗

Targeting the RAS-dependent chemoresistance: The Warburg connection.Semantic proximity Read ↗

L-Ascorbic acid preferentially kills KRAS mutant pancreatic cancer cells through DNA damageSemantic proximity Read ↗

Vitamin C (Ascorbate) and Redox Topics in CancerSemantic proximity Read ↗

Apoptosis induction in ascorbic acid treated human colorectal cancer cell lines (Caco-2)Semantic proximity Read ↗

Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future DirectionsSemantic proximity Read ↗

Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine RestrictionSemantic proximity Read ↗

Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin.Semantic proximity Read ↗

Therapeutic targeting of SLC6A8 creatine transporter inhibits KRAS mutant and wildtype colon cancer and modulates human creatine levelsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.